Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Relay Therapeutics (RLAY) Gross Margin: 2020-2025

Historic Gross Margin for Relay Therapeutics (RLAY) over the last 3 years, with Jun 2025 value amounting to 100.00%.

  • Relay Therapeutics' Gross Margin was N/A to 100.00% in Q2 2025 from the same period last year, while for Jun 2025 it was 100.00%, marking a year-over-year change of. This contributed to the annual value of 100.00% for FY2024, which is negligibly% changed negligibly from last year.
  • Per Relay Therapeutics' latest filing, its Gross Margin stood at 100.00% for Q2 2025, which was down 0.00% from 100.00% recorded in Q1 2025.
  • In the past 5 years, Relay Therapeutics' Gross Margin registered a high of 100.00% during Q1 2021, and its lowest value of 100.00% during Q1 2021.
  • In the last 3 years, Relay Therapeutics' Gross Margin had a median value of 100.00% in 2025 and averaged 100.00%.